↓ Skip to main content

Efficacy and safety of combination of empagliflozin and metformin with combination of sitagliptin and metformin during Ramadan: an observational study

Overview of attention for article published in BMC Endocrine Disorders, October 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and safety of combination of empagliflozin and metformin with combination of sitagliptin and metformin during Ramadan: an observational study
Published in
BMC Endocrine Disorders, October 2022
DOI 10.1186/s12902-022-01168-3
Pubmed ID
Authors

Ibrar Ahmed, Umar Yousaf Raja, Muhammad Umar Wahab, Tejhmal Rehman, Osama Ishtiaq, A. H. Aamir, Tahir Ghaffar, Abbas Raza, Suresh Kumar, Akhtar Sherin, Faisal Masood, Fawad Ahmad Randhawa, Ali Asghar, Sehrish Khan

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 13%
Other 2 13%
Student > Master 2 13%
Student > Doctoral Student 1 6%
Student > Ph. D. Student 1 6%
Other 0 0%
Unknown 8 50%
Readers by discipline Count As %
Medicine and Dentistry 4 25%
Unspecified 2 13%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Unknown 9 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 October 2022.
All research outputs
#15,825,047
of 23,515,383 outputs
Outputs from BMC Endocrine Disorders
#430
of 793 outputs
Outputs of similar age
#240,766
of 441,018 outputs
Outputs of similar age from BMC Endocrine Disorders
#19
of 42 outputs
Altmetric has tracked 23,515,383 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 793 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,018 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.